Gallus Biopharmaceuticals to Retain/Add 320 Jobs in Missouri
05/22/2011
Recently Gallus purchased the former 15-acre, 200,000-square-foot Centocor Biologics facility in Berkeley. The company plans to make an initial capital investment of $20 million to expand the facility, hire about 160 Centocor employees; and create about 160 new jobs over the next five years. The average salary is expected to be $88,500.
Gallus Biopharmaceuticals is a contract manufacturer of pharmaceuticals produced from cell cultures. It plans on expanding the commercially certified, FDA-approved facilities at the former Centocor plant by building a clinical services suite, expanding the existing development lab and fitting out a commercial suite.
The state of Missouri awarded Gallus a $14.6 million economic incentive package, redeemable over the next 10 years.
Project Announcements
Sun Pharmaceuticals Plans Princeton, New Jersey, Headquarters
03/18/2025
Engineered Foam Packaging Expands Bishopville, South Carolina, Operations
03/18/2025
Space Exploration Technologies Corporation Expands Bastrop, Texas, Operations
03/16/2025
Ralliant Corporation Plans Raleigh, North Carolina, Global Headquarters
03/16/2025
CG Model Tek Expands Coffee County, Tennessee, Manufacturing Operations
03/16/2025
TST Fabrication and Machine Expands Norfolk, Virginia, Headquarters-Operations
03/16/2025
Most Read
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Designing Beyond the Assembly Line
Q1 2025
-
Forging Solid Foundations
Q1 2025
-
Industries Look for Employees in Nontraditional Spaces Amid Labor Shortage
Q4 2024
-
What to Make of the Rising Trend of Salary Transparency in Job Descriptions
Q4 2024
-
Why Decarbonization Goals Start with Site Selection
Q4 2024